Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether or not cyclosporine (CsA)
combined with RTX is more effective than RTX alone in the treatment of idiopathic membranous
nephropathy (iMN).
Phase:
Phase 3
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Beijing Tongren Hospital Chinese Academy of Medical Sciences, Fuwai Hospital First Affiliated Hospital of Xinjiang Medical University Nanyang Nanshi Hospital of Henan University Shanghai Fosun Pharmaceutical Development Co, Ltd. The Luhe Teaching Hospital of the Capital Medical University The Seventh Affiliated Hospital of Sun Yat-sen University The Seventh Affiliated Hospital, Sun Yat-sen University